Episode 476
FDA considering a second Alzheimer's drug
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients.
June 13, 20238m 26s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients.
Learn more about your ad choices. Visit megaphone.fm/adchoices